Anesthetic Considerations in a Patient with Type III Spinal Muscular Atrophy [PDF]
Tsai, Elizabeth+2 more
core
Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients. [PDF]
Jung JY, Cho SA, Kwon W, Kim H, Sung TY.
europepmc +1 more source
Electroconvulsive therapy and muscle relaxants. [PDF]
Yang HS, Joung KW.
europepmc +1 more source
Pillar[6]MaxQ and Sugammadex Enhance Recovery From Rocuronium- and Vecuronium-Mediated Neuromuscular Blockade With Similar Effects in Isoflurane-Anesthetized Rats. [PDF]
Cotten JF, Isaacs L.
europepmc +1 more source
Effect of isoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade and hemodynamic responses by cisatracurium bolus injection [PDF]
Adamus+21 more
core +2 more sources
Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report. [PDF]
Kuroda H+6 more
europepmc +1 more source
Suspected Sinus Arrest After Sugammadex Administration: A Case Report. [PDF]
Uchida T+6 more
europepmc +1 more source
Hereditary pseudocholinesterase deficiency in a 4-year-old girl: a case report. [PDF]
Schulze-Berge J+6 more
europepmc +1 more source
Neuromuscular monitoring and incidence of postoperative residual neuromuscular blockade: a prospective observational study. [PDF]
Piersanti A+5 more
europepmc +1 more source